Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Ldl-Hdl'

Ldl-Hdl published presentations and documents on DocSlides.

Lifestyle Tips to Lower Your LDL Cholesterol
Lifestyle Tips to Lower Your LDL Cholesterol
by dandy
Advice f rom the National Lipid Association Clini...
PCSK9 Inhibition: LDL Lowering
PCSK9 Inhibition: LDL Lowering
by SweetiePie
PCSK9 inhibitors. New option for dyslipidemia. Ali...
LDL is causal of atherosclerosis
LDL is causal of atherosclerosis
by morgan
Evidence from . meta-analyses of . Mendelian. . r...
LDL Apheresis in Drug Resistant Nephrotic Syndrome
LDL Apheresis in Drug Resistant Nephrotic Syndrome
by obrien
Rodney D Gilbert. Patient JM. 14 year old girl, pr...
Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?
Looking to FOURIER: What do the trials tell us about LDL lowering and cardiovascular events?
by min-jolicoeur
NICE –CG 181 Continuum of CVD Risk and its trea...
Abnormalities of LDL metabolism
Abnormalities of LDL metabolism
by briana-ranney
Physiology, pathophysiology and treatments. Under...
Fats Cholesterol Saturated Fats
Fats Cholesterol Saturated Fats
by paige
Unsaturated Fats . Trans Fats . Fats. Help the bod...
Dr Kate Shipman Consultant Chemical Pathologist University Hospitals Sussex
Dr Kate Shipman Consultant Chemical Pathologist University Hospitals Sussex
by hadley
Familial Hypercholesterolaemia. 2. Learning Object...
CardioMetabolic Wellness
CardioMetabolic Wellness
by osullivan
Gary E. Foresman, MD. January 2019. What Is Middle...
Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a me
Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a me
by priscilla
ApoB. and other lipoproteins. Mendelian randomisa...
Non-obese rheumatoid arthritis patients
Non-obese rheumatoid arthritis patients
by valerie
withlow. low-density lipoprotein have higher coro...
Alirocumab Drugbank ID :
Alirocumab Drugbank ID :
by wilson
DB09302. Description. :. Alirocumab. is a biophar...
Treatment of Blood Cholesterol
Treatment of Blood Cholesterol
by daniella
to Reduce Atherosclerotic Cardiovascular . Risk in...
Putting Your Skills to the Test
Putting Your Skills to the Test
by deborah
Which ONE of the following statements regarding th...
Multi -omics Multi -omics
Multi -omics Multi -omics
by megan
Biomarkers (~13K). Genomic (~10K). Proteomic (~6K)...
A peptide that has successfully bound to PCSK9 is now able to block the low-density lipoprotein (LD
A peptide that has successfully bound to PCSK9 is now able to block the low-density lipoprotein (LD
by madeline
Publication about . this. . research. : . Y. Zhan...
1 Lipoproteins Most lipids are transported in the blood as part of
1 Lipoproteins Most lipids are transported in the blood as part of
by ashley
lipoproteins. particles whose structure includes:...
Supplements to help manage total cholesterol LDL and HDLRed Yeast Ric
Supplements to help manage total cholesterol LDL and HDLRed Yeast Ric
by margaret
RECOMMENDED WITH CAUTION Evaluated BenefitsLowerin...
American Heart Association
American Heart Association
by queenie
Check. Change. Control. ® Cholesterol WHAT ARE ...
SocietyPositionStatementCanadianCardiovascularSocietyPositionStatement
SocietyPositionStatementCanadianCardiovascularSocietyPositionStatement
by elizabeth
CanadianJournalofCardiology34(2018)1553 Receivedfo...
Copyright 2016 Wolters Kluwer Health Inc All rights reserved
Copyright 2016 Wolters Kluwer Health Inc All rights reserved
by summer
C URRENT O PINION Identifyingfamilialhypercholeste...
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 73 NUMBER 1 J
CLEVELAND CLINIC JOURNAL OF MEDICINE VOLUME 73 NUMBER 1 J
by iris
CHRISTOPHER SIBLEY,MDDepartment of Cardiology,John...
THE MANAGEMENT OF DYSLIPIDEMIA Updated Version 20 150 2006
THE MANAGEMENT OF DYSLIPIDEMIA Updated Version 20 150 2006
by ariel
VA/DoD Clinical Practice Guideline Introduction ...
6701 Carnegie Ave Suite 500 Cleveland OH 44103 p 8663589828
6701 Carnegie Ave Suite 500 Cleveland OH 44103 p 8663589828
by gelbero
ApoE genotype can affect:Response to treatment wit...
ODYSSEY FH I and II In FH I:
ODYSSEY FH I and II In FH I:
by Aquamarine
From baseline to 24 weeks, the change in . LDL-C: ...
The case for intensive lipid management:
The case for intensive lipid management:
by SillyGoose
The opportunities and issues for cardiologists. Pr...
Soodeh Razeghi PhD, Assistant professor of nutrition,
Soodeh Razeghi PhD, Assistant professor of nutrition,
by delcy
Shahid. . Beheshti. University of Medical Scienc...
DYSLIPIDEMIA IN DIABETES
DYSLIPIDEMIA IN DIABETES
by esther
MAHTAB NIROOMAND M.D.. Assistant professor of End...
A naturally randomized trial evaluating the potential clinical benefit of triglyceride lowering the
A naturally randomized trial evaluating the potential clinical benefit of triglyceride lowering the
by arya
Brian A. . Ference. MD, . MPhil. , . MSc. , John ...
The New Cholesterol Guidelines:
The New Cholesterol Guidelines:
by lily
Beauty is in the Eye of the Beholder. Brian Asbill...
Oxidized- Low Density Lipoprotein Level Among Organophosphates (OPs)
Oxidized- Low Density Lipoprotein Level Among Organophosphates (OPs)
by mediumgeneral
Pesticide Exposed Workers. Nor Zamzila Abdullah. ...
LDL Cholesterol Lowering with
LDL Cholesterol Lowering with
by shoffer
Evolocumab. and Outcomes in Patients with . Perip...
Protecting the heart and the kidney:
Protecting the heart and the kidney:
by pressio
Implications from the SHARP trial. Dr. Christina R...
HYPERLIPIDAEMIAS Dr.D.Rispa
HYPERLIPIDAEMIAS Dr.D.Rispa
by kaptainpositive
Assistant Professor. Pharmacy Practice Department....
Atherosclerosis By Aravind Kalathil, Sam Eiswirth, and Brooke Turner
Atherosclerosis By Aravind Kalathil, Sam Eiswirth, and Brooke Turner
by myesha-ticknor
Why is Atherosclerosis known as a heart disease?....
Diabetes and Dyslipidemia
Diabetes and Dyslipidemia
by danika-pritchard
2013 ACC/AHA Guideline on the. Treatment of Blood...
PCSK-9 Inhibitors Paul J
PCSK-9 Inhibitors Paul J
by tatyana-admore
PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...
LSU Journal Club Efficacy and Safety of
LSU Journal Club Efficacy and Safety of
by trish-goza
Evolocumab. in. Reducing Lipids and Cardiovascul...
Trial Design Evolocumab SC
Trial Design Evolocumab SC
by danika-pritchard
140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...
New developments in lipid management
New developments in lipid management
by pasty-toler
CGR 0800 h 11 May 2015. Rob Hegele MD FRCPC FACP....